Viewing Study NCT05412459


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2025-12-26 @ 1:14 PM
Study NCT ID: NCT05412459
Status: COMPLETED
Last Update Posted: 2023-03-06
First Post: 2022-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module